Cassava Sciences 10K Form

Sell

19

SAVA
Cassava Sciences

Last Price:

$2.40

Seasonality Move:

34.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-12	10Q	SAVA/Cassava Sciences Quarterly
2020-05-06	10Q	SAVA/Cassava Sciences Quarterly
2020-03-26	10K	SAVA/Cassava Sciences Annual
2019-10-29	10Q	SAVA/Cassava Sciences Quarterly
2019-08-12	10Q	SAVA/Cassava Sciences Quarterly
2019-05-02	10Q	SAVA/Cassava Sciences Quarterly

Receive SAVA News And Ratings

See the #1 stock for the next 7 days that we like better than SAVA

SAVA Financial Statistics

Sales & Book Value

Annual Sales:	$41.1M
Cash Flow:	$-18.3M
Price / Cash Flow:	0
Annual Sales:	$3.47
Price / Book:	0.68

Profitability

EPS (TTM):	-1.38000
Net Income (TTM):	$-17.7M
Gross Margin:	$20.6M
Return on Equity:	0%
Return on Assets:	0%

Cassava Sciences Earnings Forecast

Key Cassava Sciences Financial Ratios

The Gross Profit Margin over the past 11 years for SAVA is 100.00%.
The Selling, General & Administrative Expenses for SAVA have been equal to 11.76% of Gross Profit Margin.
Per Share Earnings over the last 25 years have been positive in 10 years.

Cassava Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	SAVA
CUSIP:	14817C
Website:	cassavasciences.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	0
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

SAVA Technical Analysis vs Fundamental Analysis

Sell

19

Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy or a Sell?

Cassava Sciences stock is rated a Sell

The current Cassava Sciences [SAVA] share price is $2.36. The Score for SAVA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.